BLFE

COM:BIOLIFESCIENCES

BioLife Sciences

  • Stock

USD

Market Cap

118

Beta: -

Volume Today

50

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Feb '21
May '21
Aug '21
Feb '22
Aug '22
Nov '22
Feb '23
May '23
Aug '23
revenue
cost of revenue
gross profit
selling and marketing expenses
57.30K
-
general and administrative expenses
selling general and administrative expenses
57.30K
-
126.23K
120.30%
134.75K
6.76%
research and development expenses
other expenses
cost and expenses
57.30K
-
126.23K
120.30%
134.75K
6.76%
operating expenses
57.30K
-
126.23K
120.30%
134.75K
6.76%
122.80
99.91%
interest expense
11.53K
-
8.41K
27.08%
ebitda
-57.30K
-
-126.23K
120.30%
-134.76K
6.76%
operating income
-57.30K
-
-126.23K
120.30%
-134.76K
6.76%
depreciation and amortization
total other income expenses net
-10.06K
-
-11.53K
14.57%
-8.40K
27.09%
income before tax
-67.36K
-
-137.76K
104.51%
-143.16K
3.93%
income tax expense
net income
-67.36K
-
-137.76K
104.51%
-143.16K
3.93%
-132.05
99.91%
weighted average shs out
54.86M
-
54.89M
0.05%
54.89M
0%
57.84K
99.89%
weighted average shs out dil
54.86M
-
54.89M
0.05%
54.89M
0%
57.83K
99.89%
eps
-0.00
-
-0.00
108.33%
-0.00
4.00%
-0.00
11.54%
0
100%
0
0
0
0
epsdiluted
-0.00
-
-0.00
108.33%
-0.00
4.00%
-0.00
11.54%
0
100%
0
0
0
0

All numbers in USD (except ratios and percentages)